ArticleInternational journal of clinical oncology2023

Effects and risk factors of TAS-102 in real-world patients with metastatic colorectal cancer, EROTAS-R study.

Naohisa Yoshida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.